Coenzyme Q10-responsive ataxia: 2-Year-treatment follow-up

Movement Disorders,  Volume 9999, Issue 9999 , PagesNA -(Articles online in advance of print)
DOI. 10.1002/mds.23129


Merce Pineda, MD, PhD ^{1 2}, Raquel Montero, PhD ^{2 3}, Asuncion Aracil, MD ^{1 2}, Mar M. O'Callaghan, MD ^{1 2}, Ana Mas, MD ⁴, Carmen Espinos, PhD ², Dolores Martinez-Rubio, BS ^{2 5}, Francesc Palau, MD, PhD ^{2 5}, Placido Navas, PhD ^{2 6}, Paz Briones, PhD ^{2 7}, Rafael Artuch, MD, PhD ^{2 3 *1}Department of Pediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain
²Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Spain
³Department of Clinical Biochemistry, Hospital Sant Joan de Déu, Barcelona, Spain
⁴Department of Pharmacy, Hospital Sant Joan de Déu, Barcelona, Spain
⁵Genetics and Medicine Molecular Unit, Instituto de Biomedicina de Valencia-CSIC, Valencia, Spain
⁶Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, Sevilla, Spain
⁷Institut de Bioquímica Clínica, Hospital Clinic and CSIC, Barcelona, Spain

email: Rafael Artuch (rartuch@hsjdbcn.org)^*Correspondence to Rafael Artuch, Department of Clinical Biochemistry, Hospital Sant Joan de Déu, Passeig Sant Joan de Déu, 2, 08950 Esplugues, Barcelona, Spain

KEYWORDS: coenzyme Q₁₀ deficiency • mitochondrial disorders • ataxia • cerebellum • pediatric patients